Israeli 'cancer shift' over heart disease mortality may be led by greater risk in women with high intake of n-6 fatty acids

European Journal of Cancer Prevention

Volumn 16, Issue 5, 2007, Pages 486-494

  Shapira, Niva ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cancer; Mediterranean; Olive oil (n 9 monounsaturated fatty acid); Omega 6 polyunsaturated fatty acids (n 6); Women

Indexed keywords

OMEGA 6 FATTY ACID; SEX HORMONE;

ARTICLE; CANCER; CANCER RISK; CARCINOGENESIS; EUROPE; HEALTH SURVEY; HEART DISEASE; HUMAN; ISRAEL; MEDITERRANEAN DIET; MORTALITY; NUTRITION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; WOMEN'S HEALTH;

FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; GENES, BRCA1; GENES, BRCA2; HEART DISEASES; HUMANS; ISRAEL; JEWS; NEOPLASMS; RISK; SEX CHARACTERISTICS;

EID: 35048817004     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3280145b6d     Document Type: Article

References (87)

1. Ailhaud G, Guesnet P (2004). Fatty acid composition of fats is an early determinant of childhood obesity: a short review and an opinion. Obesity Rev 5:21-26.
2. Bagga D, Anders KH, Wang HJ, Glaspy J (2002). Long-chain n-3-to-n-6 polyunsaturated fatty acid ratios in breast adipose tissue from women with and without breast cancer. Nutr Cancer 42:180-185.
3. Barchana M, Lifshitz I (2003). Estimation of the risk of having malignant diseases in Israel. Israel National Cancer Registry; special publication no. 8.
4. Berry EM (2001a). Are diets high in omega 6 polyunsaturated fatty acids unhealthy? Eur Heart J Suppl 39 (Suppl):D37-D41.
5. Berry EM (2001b). Who's afraid of n-6 polyunsaturated fatty acids? Methodological considerations for assessing whether they are harmful. Nut Met Cardiovasc Dis 11:181-188.
6. Binukumar B, Mathew A (2005). Dietary fat and risk of breast cancer. World J Surg Oncol 3:45-52.
7. Bitterman WA, Farhadian H, Abu Samra C, Lerner D, Amoun H, Makov UE (1991). Environmental and nutritional factors significantly associated with cancer of the urinary tract among different ethnics groups. Urol Clin N Am 18:501-508.
8. Carmichael A (2006). Obesity as a risk factor for development and poor prognosis of breast cancer. BJOG [Epub ahead of print].
9. Cohen LA, Thompson DD, Maeura Y, Choi K, Blank ME, Rose DP (1986a). Dietary fat and mammary cancer I: promoting effects of different fats on N-nitrosomethyl urea-induced rat mammary tumorigenesis. JNCI 77:33-42.
10. Cohen LA, Thompson DD, Choci K, Karmali RA, Rose DP (1986b). Dietary fat and mammary cancer II: modulation of serum and tumor lipid composition and tumor prostaglandins by different dietary fats: association with tumor incidence patterns. JNCI 77:43-51.
11. Cortesi L, Turchetti D, Marchi I, Fracca A, Canossi B, Battista R, et al. (2006). Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience. BMC Cancer 6:210 [Epub ahead of print].
12. De Deckere EA (1999). Possible beneficial effect of fish and fish n-3 polyunsaturated fatty acids in breast and colorectal cancer. Eur J Cancer Prev 8:213-221.
13. Drucker L, Stackievitz R, Shpitz B, Yarkoni S (2000). Incidence of BRCA1 and BRCA2 in Ashkenazi colorectal cancer patients: preliminary study. Anticancer Res 20:559-561.
14. Dubnov G, Berry ME (2003). Omega-6/omega-3 fatty acid ratio: the Israeli paradox. World Rev Nutr Diet 92:81-91.
15. Enig MG, Budowski P, Blondheim SH (1984). Trans-unsaturated fatty acids in margarines and human subcutaneous fat in Israel. Hum Nutr Clin Nutr 38:223-230.
16. Escrich E, Moral R, Garcia G, Costa I, Sanchez JA, Solanas M (2004). Identification of novel differentially expressed genes by the effect of a high-fat n-6 diet in experimental breast cancer. Mol Carcinog 40:73-78.
17. Fang JL, Vaca CE, Valsta LM, Mutanen M (1996). Determination of DNA adducts of malonaldehyde in humans: effects of dietary fatty acid composition. Carcinogenesis 17:1035-1040.
18. FAO (2005). Food and Agriculture Organization of the United Nations; Statistical databases, faostat nutrition, food balance sheets (1961-2002). 10 July 2005; http://faostat.fao.org/faostat/collections? subset = nutrition.
19. Feldman GE (2001). Do Ashkenazi Jews have a higher than expected cancer burden? Implications for cancer control prioritization efforts. IMAJ 3:341-346.
20. Fodor FH, Weston A, Bleiweiss IJ, McCurdy LD, Walsh MM, Tartter PI, et al. (1998). Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. Am J Hum Genet 63:45-51.
21. Franceschi S, Favero A (1999). The role of energy and fat in cancers of the breast and colon-rectum in a southern European population. Ann Oncol 10:61-63.
22. Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, et al. (2002). Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10 000 individuals. J Clin Oncol 20:1480-1490.
23. Gago-Dominguez M, Yuan JM, Sun CL, Lee HP, Yu MC (2003). Opposing effects of dietary n-3 and n-6 fatty acids and mammary carcinogenesis: the Singapore Chinese Health Study. Br J Cancer 89:1686-1992.
24. Gallus S, Bosetti C, La Vecchia C (2004). Mediterranean diet and cancer risk. Eur J Cancer Prev 13:447-452.
25. Ghafoorunissa R, Ibrahim A, Natarajan S (2005). Substituting dietary linoleic acid with alpha-linolenic acid improves insulin sensitivity in sucrose fed rats. Biochim Biophys Acta 1733:67-75.
26. Ghosh S, Lu Y, Katz A, Hu Y (2006). Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (Cyp19) in human adipose stromal cells. Am J Physiol Endocrinol Metab [Epub ahead of print].
27. Giusti RM, Rutter JL, Duray PH, Freedman LS, Konichezky M, Fisher-Fischbein J, et al. (2003). A twofold increase in BRCA mutation releated prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet 40:787-792.
28. Goodstine SL, Zheng T, Holford TR, Ward BA, Carter D, Owens PH, Mayne ST (2003). Dietary (n-3)/(n-6) fatty acid ratio: possible relationship to premenopausal but not postmenopausal breast cancer risk in U.S. women. J Nutr 133:1409-1414.
29. Green MS (1998). Differences between Israeli Jews and Arabs in morbidity and mortality rates for diseases potentially associated with dietary risk factors. Public Health Rev 26:31-40.
30. Grundy SM (1999). The optimal ratio of fat-to-carbohydrate in the diet. Annu Rev Nutr 19:325-341.
31. ICDC (1998). Trends in cancer incidence and mortality in Israel 1970-1995 (Dr Baron-Epel, editor). Gertner Institute, Sheba Medical Center, Tel Hashomer, Israel; Pub. 207.
32. ICDC (1999). Health status in Israel 1999. Main causes of death: Annual change 1975-1995. Source: Death causes files, 1969-1995 (Dr Baron-Epel, editor). Gertner Institute, Sheba Medical Center, Tel Hashomer, Israel; Pub. 213.
33. ICDC (2000). Women's health in Israel 1999-2000 data book (Ms Ifrah, editor). Gertner Institute, Sheba Medical Center, Tel Hashomer, Israel; Pub. 219.
34. ICDC (2003a). MABAT. First Israeli national health and nutrition survey 1999-2001. Part 1: general findings (Dr Nitzan Kaluski, Dir.). Gertner Institute, Sheba Medical Center, Tel Hashomer, Israel; Pub. 225.
35. ICDC (2003b). Examination of Israel National Cancer Data Accumlation Completeness for 1991. Israel: Gertner Institute, Sheba Medical Center, Tel Hashomer; No. 230.
36. ICDC (2004a). Health status in Israel 2003. General: selected measures for general population (Blau S, Ifrah A, editors). Gertner Institute, Sheba Medical Center, Tel Hashomer, Israel; Pub. 235A.
37. ICDC (2004b). MABAT. First Israeli National Health and Nutrition Survey 1999-2001. Part 2: what Israelis eat (Dr Nitzan Kaluski, Dir.). Gertner Institute, Sheba Medical Center, Tel Hashomer, Israel; Pub. 228.
38. ICDC (2005a). European Health Interview Surveys (EUROHIS). Model A: women's health. Gertner Institute, Sheba Medical Center, Tel Hashomer, Israel; Pub. 237.
39. ICDC (2005b). Health of the Arab Population in Israel 2004. Gertner Institute, Sheba Medical Center, Tel Hashomer, Israel; Pub. 226.
40. Israel Central Bureau of Statistics (ICBS) (1999). File on causes of death 1979-1999.
41. Israel Central Bureau of Statistics (ICBS) (2003). Deaths and mortality rates by cause and population group (by ICD-10).
42. Israel National Cancer Registry (INCR) (2005). Ministry of Health, Annual Reports 2005; http://www.health.gov.il/units/healthisrael. Retrieved from www.health.gov.il/icr; 30 August 2006
43. Kachhap SK, Dange P, Nath Ghosh S (2000). Effect of omega-6 polyunsaturated fatty acid (linoleic acid) on BRCA1 gene expression in MCF-7 cell line. Cancer Lett 154:115-120.
44. Kark SL (1976). Variation in the sex ratio in cardiovascular mortality. A comparative analysis of mortality in adults of different populations. Isr J Med Sci 12:1194-1206.
45. Kark JD, Kaufmann NA, Binka F, Goldberger N, Berry EM (2003). Adipose tissue n-6 fatty acids and acute myocardial infarction in a population consuming a diet high in polyunsaturated fatty acids. Am J Clin Nutr 77:796-802.
46. Kaur T, Zhang ZF (2005). Obesity, breast cancer and the role of adipocytokines. Asian Pac J Cancer Prev 6:547-552.
47. Kotsopoulos J, Narod SA (2005). Towards a dietary prevention of hereditary breast cancer. Cancer Causes Control 16:125-138.
48. Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A (2004). Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 79:935-945.
49. Levy-Lahad E, Plon SE (2003). Cancer. A risky business: assessing breast cancer risk. Science 302:574-575.
50. Liu J, Burdette JE, Sun Y, Deng S, Schlecht SM, Zheng W, et al. (2004). Isolation of linoleic acid as an estrogenic compound from the fruits of Vitex agnuscastus L. (chaste-berry). Phytomedicine 11:18-23.
51. Malone KE, Daling JR, Doody DR, Hsu L, Bernstein L, Coates RJ, et al. (2006). Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35-64 years. Cancer Res 66:8297-8308.
52. Masala G, Ambrogetti D, Assedi M, Giorgi D, Del Turco MR, Palli D (2006). Dietary and lifestyle determinants of mammographic breast density. A longitudinal study in a Mediterranean population. Int J Cancer 118:1782-1789 [Epub ahead of print].
53. McClain MR, Nathanson KL, Palomaki GE, Haddow JE (2005a). An evaluation of BRCA1 and BRCA2 founder mutations penetrance estimates for breast cancer among Ashkenazi Jewish women. Genet Med 7:34-39.
54. McClain MR, Palomaki GE, Nathanson KL, Haddow JE. (2005b). An evaluation of BRCA1 and BRCA2 founder mutations penetrance estimates for breast cancer among Ashkenazi Jewish women. Genet Med 7:28-33.
55. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R (2004a). Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and suvival: role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 APK, p27KIP1, BRCA1, and NFkappaB. Int J Oncol 24:591-608.
56. Menendez JA, Ropero S, Mehmi I, Atlas E, Colomer R, Lupu R (2004b). Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat an alter mammary tumorigenesis. Int J Oncol 24:1369-1383.
57. Menendez JA, Lupu R, Colomer R (2005a). Exogenous supplements with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22: 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erb B-2) oncogene expression in human breast cancer cells. Eur J Cancer Prev 14:263-270.
58. Menendez JA, Vellon L, Colomer R, Lupu R (2005b). Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2(erbB-2) expression and synergistically enhances the growth inhibitory effects to trastuzumab (Herceptin TM) in breast cancer cells with Her-2oncogene amplification. Ann Oncol 16:359-371.
59. Nair J, Vaca CE, Velic I, Mutanen M, Valsta LM, Bartsch H (1997). High dietary omega-6 polyunsaturated fatty acids drastically increase the formation of etheno-DNA base adducts in white blood cells of female subjects. Cancer Epidemiol Biomarkers Prev 6:597-601.
60. Okuyama H, Kobayashi T, Watanabe S (1996). Dietary fatty acids: the n-6/n-3 balance and chronic elderly diseases. Excess linoleic acid and relative n-3 deficiency syndrome seen in Japan. Prog Lipid Res 35:409-457.
61. Palli D, Masala G, Mariani-Costantini R, Zanna I, Saieva C, Sera F, et al. (2004). A gene-environment interaction between occupation and BRCA1/BRCA2 mutations in male breast cancer? Eur J Cancer 40:2474-2479.
62. Reddy BS, Maeura Y (1984). Tumor promotion by dietary fat in azoxymethane induced colon carcinogenesis in female F 344 rats: influence of amount and source of dietary fat. JNCI 72:745-750.
63. Reyes N, Reyes I, Tiwari R, Geliebler J (2004). Effect of linoleic acid on proliferation and gene expression in the breast cancer cell line T47D. Cancer Lett 209:25-35.
64. Robson M, Dabney MK, Rosenthal G, Ludwig S, Seltzer MH, Gilewski T, et al. (1997). Prevalence of recurring BRCA mutations among Ashkenazi Jewish women with breast cancer. Genet Test 1:47-51.
65. Rojas-Molina M, Campos-Sanchez J, Analla M, Munoz-Serrano A, Alonso-Moraga A (2005). Genotoxicity of vegetable cooking oils in the Drosophila wing spot test. Environ Mol Mutagen 45:90-95.
66. Rose DP, Connolly JM (2000). Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids. Nutr Cancer 37:119-127.
67. Rose DP, Gilhooly EM, Nixon DW (2002). Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin [review]. Int J Oncol 21:1285-1292.
68. Rubinstein WS (2004). Hereditary breast cancer in Jews. Fam Cancer 3:249-257.
69. Rustan AC, Nenseter MS, Drevon CA (1997). Omega 3 and omega 6 fatty acids in the insulin resistance syndrome. Ann NY Acad Sci 827:310-326.
70. Sacks FM, Campos H (2006). Polyunsaturated fatty acids, inflammation, and cardiovascular disease: time to widen our view of the mechanisms. J Clin Endocrinol Metab 91:398-400.
71. Satagopan JM, Offit K, Foulkes W, Robson ME, Wacholder S, Eng CM, et al. (2001). The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev 10:467-473.
72. Shapira N (1992). Sexual dimorphism in preventive nutrition: implications to women's health risks. The XIth International Congress of Dietetics Nutrition & Women's Health Israel, 22-27 March 1992.
73. Simchoni S, Friedman E, Kaufman B, Gershoni-Baruch R, Orr-Urtreger A, Kedar-Barnes I, et al. (2006). Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. Proc Natl Acad Sci U S A 103:3770-3774.
74. Simopoulos AP (2001). The Mediterranean diets: what is so special about the diet of Greece? The scientific evidence. J Nutr 131:3065S- 3073S.
75. Simopoulos AP (2004). The traditional diet of Greece and cancer. Eur J Cancer Prev 13:219-230.
76. Stephenson GD, Rose DP (2003). Breast cancer and obesity: an update. Nutr Cancer 45:1-16.
77. Struewing JP, Hartge P, Wacholder S, Baker M, Berlin M, McAdams M, et al. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 15:1401-1408.
78. Sugano M, Hirahara F (2000). Polyunsaturated fatty acids in the food chain in Japan. Am J Clin Nutr 71:189S-196S.
79. Trichopoulou A, Katsouyanni K, Stuver S, Tzala L, Gnardellis C, Rimm E, Trichopoulos D (1995). Consumption of olive oil and specific food groups in relation to breast cancer risk in Greece. J Natl Cancer Inst 87:110-116.
80. Vazina A, Baniel J, Yaacobi Y, Shtriker A, Engelstein D, Leibovitz I, et al. (2000). The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel. Br J Cancer 83:463-466.
81. Vehmanen P, Friedman LS, Eerola H, McClure M, Ward B, Sarantaus L, et al. (1997). Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Hum Mol Genet 6:2309-2315.
82. Wakai K, Tamakoshi K, Date C, Fukui M, Suzuki S, Lin Y, et al. JACC Study Group. (2005). Dietary intakes of fat and fatty acids and risk of breast cancer: a prospective study in Japan. Cancer Sci 96:590-599.
83. WHO (1996). Highlights on Health in Israel 1996. Changing patterns of Food consumption in Europe 1970-1990. WHO Regional Office for Europe.
84. WHO (2000). Health statistics and information systems. Estimates of child and adult mortality and life expectancy at birth by country. Annual 2000: health systems - improving performance.
85. WHO (2004). Highlights on Health in Israel 2004. Burden of disease. WHO Regional Office for Europe.
86. Wirfalt E, Mattisson L, Gullberg B, Johansson U, Olsson H, Berglund G (2002). Postmenopausal breast cancer is associated with high intakes of omega 6 fatty acids. Cancer Causes Control 13:883-893.
87. Yam D, Eliraz A, Berry EM (1996). Diet and disease: the Israeli paradox: possible dangers of a high omega 6 polyunsaturated fatty acid diet. Isr J Med Sci 32:1134-1143.